<?xml version="1.0" encoding="UTF-8"?>
<p>Invasive Pulmonary Aspergillosis (IPA) is a severe disease that can develop in immunocompromised hosts, such as individuals with neutropenia, those treated for hematological malignancies, and recipients of hematopoietic stem cell (HSCT) or solid organ transplantation (SOT) [
 <xref rid="cit0001" ref-type="bibr">1â€“3</xref>]. Despite improvements in antifungal therapy and the availability of better diagnostic tools, the detection, definitive diagnosis, and treatment of this disease remains challenging.
</p>
